➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Merck
McKesson
Mallinckrodt
AstraZeneca

Last Updated: July 28, 2021

DrugPatentWatch Database Preview

Patent: 10,071,953

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,071,953
Title:Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof
Abstract: The invention includes compositions comprising selective AKR1C3 inhibitors. The invention also includes compositions comprising bifunctional AKR1C3 inhibitors and selective androgen receptor modulators. The invention further includes methods of treatment using the compositions of the invention.
Inventor(s): Penning; Trevor M. (Springfield, PA), Adeniji; Adegoke O. (Drexel Hill, PA), Byrns; Michael C. (Philadelphia, PA), Winkler; Jeffrey (Wynnewood, PA), Twenter; Barry (Philadelphia, PA)
Assignee: The Trustees of the University of Pennsylvania (Philadelphia, PA)
Application Number:14/993,742
Patent Claims:see list of patent claims

Details for Patent 10,071,953

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Dendreon Pharmaceuticals Llc PROVENGE sipuleucel-t INJECTION 125197 1 2010-04-29 ⤷  Free Forever Trial The Trustees of the University of Pennsylvania (Philadelphia, PA) 2031-04-13 search
Dendreon Pharmaceuticals Llc PROVENGE sipuleucel-t INJECTION 125197 001 2010-04-29 ⤷  Free Forever Trial The Trustees of the University of Pennsylvania (Philadelphia, PA) 2031-04-13 search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ⤷  Free Forever Trial The Trustees of the University of Pennsylvania (Philadelphia, PA) 2031-04-13 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ⤷  Free Forever Trial The Trustees of the University of Pennsylvania (Philadelphia, PA) 2031-04-13 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Merck
McKesson
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.